Cognitive-behavioral treatment of depression, Part VI: Integrating the use of antidepressant medications

Journal of Contemporary Psychotherapy

Volumn 26, Issue 3, 1996, Pages 235-250

  Overholser, James C ^a   Schubert, Daniel S P ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038264958     PISSN: 00220116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02307589     Document Type: Article

References (74)

1. Alford, G., & Williams, J. (1980). The role and uses of psychopharmacological agents in behavior therapy. Progress in Behavior Modification, 10, 207-240.
2. Ambrosini, P., Bianchi, M., Rabinovich, H., & Elia, J. (1993). Antidepressant treatments in children and adolescents. I. Affective disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1-6.
3. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, D.C.: American Psychiatric Association.
4. Antonuccio, D., Danton, W., & DeNelsky, G. (1995). Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 26, 574-585.
5. Badal, D. (1988). Treatment of depression and related moods: A manual for psychotherapists. Northvale, N.J.: Jason Aronson.
6. Badager, L., DeGruy, F., Hartman, J., Plant, M., Leeper, J., Anderson, R., Ficken, R., Gaskins, S., Maxwell, A., Rand, E., & Tietze, P. (1994). Patient presentation, interview content, and the detection of depression by primary care physicians. Psychosomatic Medicine, 56, 128-135.
7. Beck, A. T., Hollon, S., Young, J., Bedrosian, R., & Budenz, D. (1985). Treatment of depression with cognitive therapy and amitriptyline. Archives of General Psychiatry, 42, 142-148.
8. Beck, A. T., Rush, A. J., Shaw, B., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford.
9. Beckham, E., & Leber, W. (1985). The comparative efficacy of psychotherapy and pharmacotherapy for depression. In E. Beckham & W. Leber (Eds.), Handbook of depression: Treatment, assessment, and research, (pp. 316-340). Homèwood, IL: Dorsey Press.
10. Blaine, J., Prien, R., & Levine, J. (1983). The role of antidepressants in the treatment of affective disorders. American Journal of Psychotherapy, 37, 502-520.
11. Blazer, D. (1982). Depression in late life. St. Louis: Mosby.
12. Brockington, I., Altman, E., Hillier, V., Meltzer, H., & Nand, S. (1982). The clinical picture of bipolar affective disorder in its depressed phase. British Journal of Psychiatry, 141, 558-562.
13. Brown, R., Frances, A., Kocsis, J., & Mann, J. (1982). Psychotic vs. nonpsychotic depression: Comparison of treatment response. Journal of Nervous and Mental Disease, 170, 635-637.
14. Byrne, K., & Stern, S. (1981). Antidepressant medication in the outpatient treatment of depression: Guide for nonmedical psychotherapists. Professional Psychology, 12, 302-308.
15. Cassem, N. (1982). Cardiovascular effects of antidepressants. Journal of Clinical Psychiatry, 43, 22-28.
16. Charney, D., Heninger, G., Sternberg, D., & Landis, H. (1982). Abrupt discontinuation of tricyclic antidepressant drugs: Evidence for noradrenergic hyperactivity. British Journal of Psychiatry, 141, 377-386.
17. Charney, D., Miller, H., Licinio, J., & Salomon, R. (1995). Treatment of depression. In A. F. Schatzberg, & C. B. Nemeroff (Eds.), Textbook of psychopharmacology, (pp. 575-601). Washington, D.C.: American Psychiatric Press.
18. Charney, D. & Nelson, J. C. (1981). Delusional and nondelusional unipolar depression: Further evidence for distinct subtypes. American Journal of Psychiatry, 138, 328-333.
19. Cole, J. (1983). Antidepressant drug therapy in the elderly. In J. Davis & J. Maas (Eds.), The affective disorders, (pp. 385-391). Washington, D.C.: American Psychiatric Press.
20. Conte, H., Plutchik, R., Wild, K., & Karasu, T. (1986). Combined psychotherapy and pharmacotherapy for depression. Archives of General Psychiatry, 43, 471-479.
21. Depression Panel Guideline. (1993). Depression in primary care: Volume 2. Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publicaton No. 93-0551.
22. Depue, R. & Monroe, S. (1978). The unipolar-bipolar distinction in the depressive disorders. Psychological Bulletin, 85, 1001-1029.
23. Elkin, I., Shea, T., Watkins, J., Imber, S., Sotsky, S., Collins, J., Glass, D., Pilkonis, P., Leber, W., Docherty, J., Fiester, S., & Parloff, M. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Archives of General Psychiatry, 46, 971-982.
24. Evans, M., Hollon, S., DeRubeis, R., Piasecki, J., Grove, W., Garvey, M., & Tuason, V. (1992). Differential relapse following cognitive therapy and pharmacology for depression. Archives of General Psychiatry, 49, 802-808.
25. Friedel, R. (1982). The relationship of therapeutic response to antidepressant plasma levels: An update. Journal of Clinical Psychiatry, 43, 37-42.
26. Greenberg, R., Bornstein, R., Greenberg, M., & Fisher, S. (1992). A meta-analysis of anti-depressant outcome under "blinder" conditions. Journal of Consulting and Clinical Psychology, 60, 664-669.
27. Hollon, S., DeRubeis, R., Evans, M., Wiemer, M., Garvey, M., Grove, W., & Tuason, V. (1992). Cognitive therapy and pharmacotherapy for depression: Singly and in combination. Archives of General Psychiary, 49, 774-781.
28. Hollon, S., Shelton, R., & Loosen, P. (1991). Cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology, 59, 88-99.
29. Howland, R. H. (1991). Pharmacotherapy of dysthymia: A review. Journal of Clinical Psychopharmacology, 11, 83-92.
30. Ilardi, S. & Craighead, W. E. (1994/1995). Personality pathology and response to somatic treatments for major depression: A critical review. Depression, 2, 200-217.
31. Karasu, T. (1982). Psychotherapy and pharmacotherapy: Toward an integrative model. American Journal of Psychiatry, 139, 1102-1113.
32. Krishnan, K. R. (1995). Monoaine oxidase inhibitors. In A. F. Schatzberg, & C. B. Nemeroff, (Eds.), Textbook of psychopharmacology, (pp. 183-193). Washington, D.C.: American Psychiatric Press.
33. Lader, M. (1980). Introduction to psychopharmacology. Kalamazoo, MI: Upjohn.
34. Lenox, R. H., & Manji, H. K. (1995). Lithium. In A. F. Schatzberg, & C. B. Nemeroff, (Eds.), Textbook of psychopharmacology, (pp. 303-349). Washington, D.C.: American Psychiatric Press.
35. Lydiard, R. B. (1985). Tricyclic-resistant depression: Treatment resistance or inadequate treatment? Journal of Clinical Psychiatry, 46, 412-417.
36. McCabe, B. & Tsuang, M. (1982). Dietary consideration in MAO Inhibitor regimens. Journal of Clinical Psychiatry, 43, 178-181.
37. McElroy, S. & Keck, P. (1995). Anti-epileptic drugs. In A. F. Schatzberg, & C. B. Nemeroff (Eds.), Textbook of psychopharmacology, (pp. 351-375). Washington, D.C.: American Psychiatric Press.
38. McNeal, E. & Cimbolic, P. (1986). Andidepressants and biochemical theories of depression. Psychological Bulletin, 99, 361-374.
39. Miller, I., Norman, W., & Keitner, G. (1989a). Cognitive-behavioral treatment of depressed inpatients: Sk and twelve-month follow-up. American Journal of Psychiatry, 146, 1274-1279.
40. Miller, I., Norman W., Keitner, G., Bishop, S., & Dow, M. (1989b). Cognitive-behavioral treatment of depressed inpatients. Behavior Therapy, 20, 25-47.
41. Morris, J., & Beck, A. T. (1974). The efficacy of antidepressant drugs: A review of research (1958 to 1972). Archives of General Psychiatry, 30, 667-674.
42. Munoz, R., Hollon, S., McGrath, E., Rehm, L., & Vandenbos, G. (1994). On the AHCPR Depression in Primary Care guidelines: Further considerations for practitioners. American Psychologist, 49, 42-61.
43. Murphy, G., Simons, A., Wetzel, R., & Lustman, P. (1984). Cognitive therapy and pharmacotherapy: Singly and together in the treatment of depression. Archives of General Psychiatry, 41, 33-41.
44. Nelson, J. C., Mazure, C., Quinlan, D., & Jatlow, P. (1984). Drug-responsive symptoms in melancholia. Archives of General Psychiatry, 41, 663-668.
45. Overholser, J. C. (1995a). Cognitive-behavioral treatment of depression, Part I: Assessment of depression and suicide risk. Journal of Contemporary Psychotherapy, 25, 185-204.
46. Overholser, J. C. (1995b). Cognitive-behavioral treatment of depression, Part II: Techniques for improving social functioning. Journal of Contemporary Psychotherapy, 25, 205-222.
47. Overholser, J. C. (1995c). Cognitive-behavioral treatment of depression, Part III: Reducing cognitive biases. Journal of Contemporary Psychotherapy, 25, 311-329.
48. Overholser, J. C. (1996a). Cognitive-behavioral treatment of depression, Part IV: Improving problem-solving skills. Journal of Contemporary Psychotherapy, 26, 43-57.
49. Overholser, J. C. (1996b). Cognitive-behavioral treatment of depression, Part V: Enhancing self-esteem and self-control. Journal of Contemporary Psychotherapy, 26, 163-176.
50. Pollack, M., & Rosenbaum, J. (1987). Management of antidepressant-induced side effects: A practical guide for the clinician. Journal of Clinical Psychiatry, 48, 3-8.
51. Potter, W., Manji, H., & Rudorfer, M. (1995). Tricyclics and tetracyclics. In A. F. Schatzberg, & C. B. Nemeroff, (Eds.), Textbook of psychopharmacology, (pp. 141-160). Washington, D.C.: American Psychiatric Press.
52. Quitkin, F., Rifkin, A., & Klein, D. (1979). Monoamine oxidase inhibitors: A review of anti-depressant effectiveness. Archives of General Psychiatry, 36, 749-760.
53. Reisberg, B. & Gershon, S. (1979). Side effects associated with lithium therapy. Archives of General Psychiatry, 36, 879-887.
54. Risch, S., Huey, L, & Janowsky, D. (1979). Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. Journal of Clinical Psychiatry, 40, 4-16.
55. Rodin, G., & Voshart, K. (1986). Depression in the medically ill: An overview. American Journal of Psychiatry, 143, 696-705.
56. Rush, A. J., Kovacs, M., Beck, A. T., Weissenburger, J., & Hollon, S. (1981). Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. Journal of Affective Disorders, 3, 221-229.
57. Schuckit, M. (1995). Drug and alcohol abuse, (4th Ed.). New York: Plenum.
58. Segraves, R. T., (1992). Sexual dysfunction complicating the treatment of depression. Journal of Clinical Psychiatry, 10, 75-83.
59. Simons, A., Garfield, S., & Murphy, G. (1984). The process of change in cognitive therapy and pharmacotherapy for depression: Changes in mood and cognition. Archives of General Psychiatry, 41, 45-51.
60. Simons, A., Murphy, G., Levine, J., & Wetzel, R. (1986). Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year. Archives of General Psychiatry, 43, 43-48.
61. Solomon, D., Keitner, G., Miller, I., Shea, M. T., & Keller, M. (1995). Course of illness and maintenance treatments for patients with bipolar disorder. Journal of Clinical Psychiatry, 56, 5-13.
62. Spiker, D., Weiss, J., Dealy, R., Griffin, S., Hanin, I., Neil, J., Perel, J., Rossi, A., & Soloff, P. (1985). The pharmacological treatment of delusional depression. American Journal of Psychiatry, 142, 430-436.
63. Sterling-Smith, R. (1974). A medical toxicology index: An evaluation of commonly used suicidal drugs. In A. T. Beck, H. Resnick, & D. Lettieri (Eds.), The prediction of suicide, (pp. 214-220). Maryland: Charles Press.
64. Stern, S., Rush, A. J., & Mendels, J. (1980). Toward a rational pharmacotherapy of depression. American Journal of Psychiatry, 137, 545-552.
65. Teasdale, J., Fennell, M., Hibbert, G., & Amies, P. (1984). Cognitive therapy for major depressive disorder in primary care. British Journal of Psychiatry, 144, 400-406.
66. Tollefson, G. (1995). Selective serotonin reuptake inhibitors. In A. F. Schatzberg, & C. B. Nemeroff, (Eds.), Textbook of psychopharmacology, (pp. 161-182). Washington, D.C.: American Psychiatric Press.
67. Vlissides, D., & Jenner, F. (1982). The response of endogenously and reactively depressed patients to electroconvulsive therapy. British Journal of Psychiatry, 141, 239-242.
68. Weissman, M. (1979). Psychological treatment of depression: Evidence for the efficacy of psychotherapy alone, in comparison with an in combination with pharmacotherapy. Archives of General Psychiatry, 36, 1262-1269.
69. Weissman, M. (1983). Psychotherapy in comparison and in combination with pharmacotherapy for the depressed outpatient. In J. Davis, & J. Maas (Eds.), The affective disorders, (pp. 409-418). Washington, D.C.: American Psychiatric Press.
70. Weissman, M., Prusoff, B., DiMascio, A., Neu, C., Goklaney, M., & Klerman, G. (1979). The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. American Journal of Psychiatry, 136, 555-558.
71. Wexler, B. & Cicchetti, D. (1992). The outpatient treatment of depression: Implications of outcome research for clinical practice. Journal of Nervous and Mental Disease, 180, 277-286.
72. Williams, J. (1992). The psychological treatment of depression: A guide to the theory and practice of cognitive behaviour therapy (2nd edition). New York: Routledge.
73. Wright, J., Thase, M., & Sensky, T. (1993). Cognitive and biological therapies: A combined approach. In J. Wright, M. Thase, A. Beck, & J. Ludgate (Eds.), Cognitive therapy with inpatients: Developing a cognitive milieu, (pp. 193-218). New York: Guilford.
74. Zaretsky, A., & Segal, Z. (1994/1995). Psychosocial intervention in bipolar disorder. Depression, 2, 179-188.